Relpax price
Executive Summary
Pfizer launches migraine agent Relpax (eletriptan) at $15.80 per tablet; packages of 12 tablets of either strength (20 mg or 40 mg) list for $189.60 AWP. The price is a slight discount to GSK's Imitrex (sumatriptan), which lists for $17.17 per 50 mg tablet. FDA approved Relpax Dec. 26 (1"The Pink Sheet" Jan. 6, p. 5)...
You may also be interested in...
Pfizer Relpax To Launch In First Quarter At Maximum Dose Of 40 Mg
Pfizer's Relpax migraine treatment will be launched during the first quarter at a maximum dose of 40 mg
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.